General Information
BounceWatch is an independent company data service, not affiliated with Promedior. To contact Promedior, visit promedior.com.
Is this your company?
Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.
Get Verified
How does Promedior compare?
A PDF of Promedior and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.
This takes a few seconds: we look beyond our own index too.
Meeting Promedior soon?
A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample
Discover More
About Promedior
Business keywords: biopharmaceutical, drug discovery, therapeutics, fibrotic diseases, inflammatory diseases, clinical-stage, monocyte-derived cell populations, immunotherapy, tissue healing, precision medicine, autoimmune conditions, eye diseases, lung diseases, kidney diseases, novel therapeutics
Funding Rounds & Investors (7)
View All| Funding Stage | Amount | Investors | Lead Investors | Date |
|---|---|---|---|---|
| Venture Round | Undisclosed | 1 | 01 Jan 2019 | |
| Series D | $3.00M | 7 | 15 Oct 2012 | |
| Series D | $21.50M | 6 | 07 Mar 2012 | |
| Debt Financing | $6.50M | - |
|
17 Oct 2011 |
| Series C | $12.00M | 1 | 17 Mar 2010 | |
| Series B | $6.00M | - |
|
25 Feb 2009 |
| Series A | $14.00M | 5 | 24 May 2006 |
Promedior Alternatives & Competitors
View All AlternativesDeveloping innovative precision therapies for the treatment of inflammatory and fibrotic diseases
Building a leading biotech company focused in severe autoimmune diseases.
Transforming patient health by delivering innovative immunology therapeutics.
FAQ About Promedior
Source: BounceWatch company record for Promedior, https://bouncewatch.com/company/promedior, updated 28 October 2024. When citing, please name BounceWatch and link this page.